Surgical series of metastatic cerebral melanoma: Clinical association of resection, BRAF-mutation status, and survival
Background: Major advances in the systemic treatment of metastatic cerebral melanoma have improved patient survival. The clinical relationship between gross total resection (GTR), BRAF-mutation status, and its effects on survival in the era of targeted/immunotherapy warrants further characterization...
Main Authors: | M.J. Colditz, S.F. Lee, M. Eastgate, S. Elder, P. Brandis, D. Anderson, T. Withers, R.L. Jeffree, M.B. Pinkham, S. Olson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Interdisciplinary Neurosurgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214751920306368 |
Similar Items
-
Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
by: Polsky David, et al.
Published: (2004-12-01) -
The role of BRAF V600 mutation in melanoma
by: Ascierto Paolo A, et al.
Published: (2012-07-01) -
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
by: Ilaria Proietti, et al.
Published: (2020-09-01) -
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
by: Ernesto Rossi, et al.
Published: (2019-04-01) -
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
by: V. Doma, et al.
Published: (2019-08-01)